HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,884 | -5.8% | 310 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $33,833 | +430.9% | 310 | +453.6% | 0.01% | +400.0% |
| Q4 2022 | $6,373 | -83.2% | 56 | -90.9% | 0.00% | -85.7% |
| Q3 2022 | $38,000 | +90.0% | 617 | +144.8% | 0.01% | +133.3% |
| Q2 2022 | $20,000 | -16.7% | 252 | +11.5% | 0.00% | -25.0% |
| Q1 2022 | $24,000 | +300.0% | 226 | +303.6% | 0.00% | +300.0% |
| Q4 2021 | $6,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $6,000 | -80.6% | 56 | -83.3% | 0.00% | -87.5% |
| Q2 2021 | $31,000 | +158.3% | 335 | +148.1% | 0.01% | +166.7% |
| Q1 2021 | $12,000 | -14.3% | 135 | -29.3% | 0.00% | -25.0% |
| Q4 2020 | $14,000 | -6.7% | 191 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $15,000 | +87.5% | 191 | +41.5% | 0.01% | +66.7% |
| Q2 2020 | $8,000 | +100.0% | 135 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $4,000 | – | 135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 6,100,000 | $377,529,000 | 27.63% |
| Kopp Family Office, LLC | 542,543 | $33,578,000 | 27.33% |
| Prosight Management, LP | 303,000 | $18,753,000 | 10.05% |
| Eversept Partners, LP | 1,269,591 | $78,574,987 | 6.81% |
| Octagon Capital Advisors LP | 624,500 | $38,650,000 | 6.67% |
| Avoro Capital Advisors LLC | 5,125,000 | $317,186,000 | 5.86% |
| 1492 Capital Management LLC | 119,836 | $7,417,000 | 5.34% |
| Velan Capital Investment Management LP | 68,829 | $4,260,000 | 4.22% |
| Deep Track Capital, LP | 1,462,800 | $90,533,000 | 4.15% |
| Ally Bridge Group (NY) LLC | 74,262 | $4,596,000 | 3.03% |